Basavaraj S. Aski, N. Biradar, S. Walvekar, G. Naregal, Nikil. N. Biradar
{"title":"石榴汁、降糖治疗对血糖控制和脂质亚组分状态的影响","authors":"Basavaraj S. Aski, N. Biradar, S. Walvekar, G. Naregal, Nikil. N. Biradar","doi":"10.22376/ijpbs.2022.13.3.b25-31","DOIUrl":null,"url":null,"abstract":"Over the last decade, studies have linked the beneficial effect of pomegranate juice on glycemic control. They have a significant secretory influence on beta-cell, carbohydrate, and lipid metabolism turnover in preventing and treating type ii diabetes. However, hypoglycaemic drugs have side effects such as lactic acidosis and abdominal discomfort. Hence, we aimed for a new treatment regime that included oral antidiabetic drugs and pomegranate juice, which works as an anti-oxidant and a potential antidiabetic agent. The study included randomly chosen145 type 2 diabetes mellitus male subjects and 36 healthy male participants. The study was carried out in two stages. Initially, all subjects were allowed to be on their respective antidiabetic drugs/insulin and to have a regular check-up of blood glucose twice a week for four weeks, after which they were redistributed into three groups, one of which was given pomegranate juice along with their respective antidiabetic drugs. After a 4-week run-in period, patients improved their ability to self-monitor blood glucose values and a wash-out period of 3 weeks, during which oral hypoglycaemic drugs and insulin were discontinued. The subjects were randomly assigned to follow the treatment protocol. Subjects received either an antidiabetic medicine or insulin, while the others received 200 ml of pomegranate fruit juice every day, along with antidiabetic therapy assigned to two-month treatment intervals. Glycemic rate and lipid profile changes were observed at the end of the period. The subjects with Pomegranate Juice with drug treatment showed a significant reduction in the levels of HbAlc (6.2 ± 0.2% vs. 8.2 ± 0.3%.)), LDL cholesterol concentration (120.61 ± 12.81, vs 136.23 ± 16.58 mg/dl P < 0.05), and Phospotidyl choline (27.20 ± 1.98 vs 22.80 ± 2.20 mg/cc. P < 0.05 as compared to other groups. This study has observed that pomegranate juice combined with an antidiabetic therapy regime has outstanding potential advantages in glucose control and a significant reduction in dyslipidemia and increased phospholipids levels compared to insulin or drug alone. These changes are linked to disease progression in numerous tissues. Pomegranate juice therapy may lower the need for diabetic medication or insulin, and natural diet fruits may impact pancreatic cell activation.","PeriodicalId":14279,"journal":{"name":"International journal of pharma and bio sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Pomegranate Juice, Antidiabetic Therapy on Glycemic Control and Lipid Subfraction Status\",\"authors\":\"Basavaraj S. Aski, N. Biradar, S. Walvekar, G. Naregal, Nikil. N. Biradar\",\"doi\":\"10.22376/ijpbs.2022.13.3.b25-31\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Over the last decade, studies have linked the beneficial effect of pomegranate juice on glycemic control. They have a significant secretory influence on beta-cell, carbohydrate, and lipid metabolism turnover in preventing and treating type ii diabetes. However, hypoglycaemic drugs have side effects such as lactic acidosis and abdominal discomfort. Hence, we aimed for a new treatment regime that included oral antidiabetic drugs and pomegranate juice, which works as an anti-oxidant and a potential antidiabetic agent. The study included randomly chosen145 type 2 diabetes mellitus male subjects and 36 healthy male participants. The study was carried out in two stages. Initially, all subjects were allowed to be on their respective antidiabetic drugs/insulin and to have a regular check-up of blood glucose twice a week for four weeks, after which they were redistributed into three groups, one of which was given pomegranate juice along with their respective antidiabetic drugs. After a 4-week run-in period, patients improved their ability to self-monitor blood glucose values and a wash-out period of 3 weeks, during which oral hypoglycaemic drugs and insulin were discontinued. The subjects were randomly assigned to follow the treatment protocol. Subjects received either an antidiabetic medicine or insulin, while the others received 200 ml of pomegranate fruit juice every day, along with antidiabetic therapy assigned to two-month treatment intervals. Glycemic rate and lipid profile changes were observed at the end of the period. The subjects with Pomegranate Juice with drug treatment showed a significant reduction in the levels of HbAlc (6.2 ± 0.2% vs. 8.2 ± 0.3%.)), LDL cholesterol concentration (120.61 ± 12.81, vs 136.23 ± 16.58 mg/dl P < 0.05), and Phospotidyl choline (27.20 ± 1.98 vs 22.80 ± 2.20 mg/cc. P < 0.05 as compared to other groups. This study has observed that pomegranate juice combined with an antidiabetic therapy regime has outstanding potential advantages in glucose control and a significant reduction in dyslipidemia and increased phospholipids levels compared to insulin or drug alone. These changes are linked to disease progression in numerous tissues. Pomegranate juice therapy may lower the need for diabetic medication or insulin, and natural diet fruits may impact pancreatic cell activation.\",\"PeriodicalId\":14279,\"journal\":{\"name\":\"International journal of pharma and bio sciences\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of pharma and bio sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22376/ijpbs.2022.13.3.b25-31\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pharma and bio sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22376/ijpbs.2022.13.3.b25-31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在过去的十年里,研究已经将石榴汁对血糖控制的有益作用联系起来。它们在预防和治疗ii型糖尿病中对β细胞、碳水化合物和脂质代谢转换有显著的分泌影响。然而,降糖药有副作用,如乳酸酸中毒和腹部不适。因此,我们的目标是一种新的治疗方案,包括口服降糖药和石榴汁,石榴汁作为一种抗氧化剂和潜在的降糖剂。该研究包括随机选择145名2型糖尿病男性受试者和36名健康男性受试者。这项研究分两个阶段进行。最初,所有受试者都被允许服用各自的降糖药/胰岛素,并每周两次定期检查血糖,持续四周,之后他们被重新分配到三组,其中一组服用石榴汁和各自的降糖药。经过4周的磨合期后,患者自我监测血糖值的能力有所提高,并有3周的洗脱期,在此期间停用口服降糖药和胰岛素。受试者被随机分配遵循治疗方案。受试者接受降糖药或胰岛素治疗,而其他人每天接受200毫升石榴汁,并按照两个月的治疗间隔接受降糖药治疗。在实验结束时观察血糖率和血脂变化。石榴汁联合药物治疗组HbAlc水平(6.2±0.2% vs 8.2±0.3%)、LDL胆固醇浓度(120.61±12.81 vs 136.23±16.58 mg/dl P < 0.05)、磷脂酰胆碱(27.20±1.98 vs 22.80±2.20 mg/cc)均显著降低。与其他组比较P < 0.05。该研究发现,与单独使用胰岛素或药物相比,石榴汁联合抗糖尿病治疗方案在控制血糖、显著降低血脂异常和增加磷脂水平方面具有突出的潜在优势。这些变化与许多组织的疾病进展有关。石榴汁疗法可以降低对糖尿病药物或胰岛素的需求,天然饮食水果可能会影响胰腺细胞的激活。
Impact of Pomegranate Juice, Antidiabetic Therapy on Glycemic Control and Lipid Subfraction Status
Over the last decade, studies have linked the beneficial effect of pomegranate juice on glycemic control. They have a significant secretory influence on beta-cell, carbohydrate, and lipid metabolism turnover in preventing and treating type ii diabetes. However, hypoglycaemic drugs have side effects such as lactic acidosis and abdominal discomfort. Hence, we aimed for a new treatment regime that included oral antidiabetic drugs and pomegranate juice, which works as an anti-oxidant and a potential antidiabetic agent. The study included randomly chosen145 type 2 diabetes mellitus male subjects and 36 healthy male participants. The study was carried out in two stages. Initially, all subjects were allowed to be on their respective antidiabetic drugs/insulin and to have a regular check-up of blood glucose twice a week for four weeks, after which they were redistributed into three groups, one of which was given pomegranate juice along with their respective antidiabetic drugs. After a 4-week run-in period, patients improved their ability to self-monitor blood glucose values and a wash-out period of 3 weeks, during which oral hypoglycaemic drugs and insulin were discontinued. The subjects were randomly assigned to follow the treatment protocol. Subjects received either an antidiabetic medicine or insulin, while the others received 200 ml of pomegranate fruit juice every day, along with antidiabetic therapy assigned to two-month treatment intervals. Glycemic rate and lipid profile changes were observed at the end of the period. The subjects with Pomegranate Juice with drug treatment showed a significant reduction in the levels of HbAlc (6.2 ± 0.2% vs. 8.2 ± 0.3%.)), LDL cholesterol concentration (120.61 ± 12.81, vs 136.23 ± 16.58 mg/dl P < 0.05), and Phospotidyl choline (27.20 ± 1.98 vs 22.80 ± 2.20 mg/cc. P < 0.05 as compared to other groups. This study has observed that pomegranate juice combined with an antidiabetic therapy regime has outstanding potential advantages in glucose control and a significant reduction in dyslipidemia and increased phospholipids levels compared to insulin or drug alone. These changes are linked to disease progression in numerous tissues. Pomegranate juice therapy may lower the need for diabetic medication or insulin, and natural diet fruits may impact pancreatic cell activation.